Ottobock leads funding round for Blue Arbor prosthetic control technology

Medical technology company Blue Arbor Technologies announced on October 29 that it closed a 10.5 million US-dollar Series A financing round led by Ottobock, ad-hoc-news.de reported. The investment will support feasibility testing for the company's RESTORE Neuromuscular Interface System and fund preparations for clinical studies in the United States. [1]

According to ad-hoc-news.de, the funding will also help Blue Arbor prepare for a US Food and Drug Administration Investigational Device Exemption. Additionally, the Michigan-based firm plans to begin developing an implantable internal sensing unit to complement its existing external sensing system. [1]

Ottobock is based in Duderstadt, Germany, and operates as an international leader in orthopedics, prosthetics, and exoskeletons. The company previously pioneered advancements such as microprocessor-controlled prosthetic knees and has supported the Paralympic Games since 1988. Blue Arbor operates out of Michigan, where Ann Arbor serves as the county seat of Washtenaw County. [2][3][4]

The investment marks a continued global expansion of technological solutions designed to restore mobility for users. As HEROIC BREAKING NEWS reported earlier, prosthetic manufacturers continue to target international growth to improve access to adaptive technology worldwide. [5]